anti mouse tlr2 antibody Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • anti mouse tlr2 antibody  (Thermo Fisher)
    86
    Thermo Fisher anti mouse tlr2 antibody
    Anti Mouse Tlr2 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse tlr2 antibody/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti mouse tlr2 antibody - by Bioz Stars, 2023-09
    86/100 stars
    		  Buy from Supplier
    mouse anti tlr2 antibody  (Santa Cruz Biotechnology)
    86
    Santa Cruz Biotechnology mouse anti tlr2 antibody
    Mouse Anti Tlr2 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti tlr2 antibody/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mouse anti tlr2 antibody - by Bioz Stars, 2023-09
    86/100 stars
    		  Buy from Supplier
    mouse anti tlr2 antibody  (Millipore)
    86
    Millipore mouse anti tlr2 antibody
    Mouse Anti Tlr2 Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti tlr2 antibody/product/Millipore
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mouse anti tlr2 antibody - by Bioz Stars, 2023-09
    86/100 stars
    		  Buy from Supplier
    anti mouse tlr2  (PerkinElmer)
    94
    PerkinElmer anti mouse tlr2
    The expression of toll-like receptor 2 <t>(TLR2)</t> and lysosome-associated membrane protein 1 (LAMP1) on CD11b + CD45 low-med and CD11b + CD45 high cells in mild and severe brain injury after HI. (A) Percentage of <t>TLR2</t> + /CD11b + CD45 low-med fluorescence intensity at 1 day and 3 days after HI in the C group, HI-M group, and HI-S group. (B) The percentage of TLR2 + /CD11b + CD45 high fluorescence intensity at 1 day and 3 days after HI. (C) Quantification of TLR2 + /CD11b + CD45 low-med cells at 1 and 3 days after HI. (D) Quantification of TLR2 + /CD11b + CD45 high cells at 1 and 3 days after HI. (E) The percentage of LAMP1 + /CD11b + CD45 low-med fluorescence intensity at 1 day and 3 days after HI in the C group, HI-M group, and HI-S group. (F) The percentage of LAMP1 + /CD11b + CD45 high fluorescence intensity at 1 day and 3 days after HI. (G) Quantification of LAMP1 + /CD11b + CD45 low-med cells at 1 and 3 days after HI. (H) Quantification of LAMP1 + /CD11b + CD45 high cells at 1 and 3 days after HI. C, control group; HI-M, hypoxia-ischemia brain damage with mild injury; HI-S, hypoxia-ischemia brain damage with severe injury. * p < 0.05 HI-M vs. C, ** p < 0.01 HI-M vs. C, # p < 0.05 HI-S vs. C, △ p < 0.05 HI-S vs. HI-M, **** p < 0.0001 HI-M vs. C, # p < 0.05 HI-S vs. C, △ p < 0.05 HI-S vs. HI-M, n = 4–6 animals per group, data expressed as the means ± SEM.
    Anti Mouse Tlr2, supplied by PerkinElmer, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse tlr2/product/PerkinElmer
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti mouse tlr2 - by Bioz Stars, 2023-09
    94/100 stars
    		  Buy from Supplier
    anti mouse tlr2  (InvivoGen)
    93
    InvivoGen anti mouse tlr2
    The expression of toll-like receptor 2 <t>(TLR2)</t> and lysosome-associated membrane protein 1 (LAMP1) on CD11b + CD45 low-med and CD11b + CD45 high cells in mild and severe brain injury after HI. (A) Percentage of <t>TLR2</t> + /CD11b + CD45 low-med fluorescence intensity at 1 day and 3 days after HI in the C group, HI-M group, and HI-S group. (B) The percentage of TLR2 + /CD11b + CD45 high fluorescence intensity at 1 day and 3 days after HI. (C) Quantification of TLR2 + /CD11b + CD45 low-med cells at 1 and 3 days after HI. (D) Quantification of TLR2 + /CD11b + CD45 high cells at 1 and 3 days after HI. (E) The percentage of LAMP1 + /CD11b + CD45 low-med fluorescence intensity at 1 day and 3 days after HI in the C group, HI-M group, and HI-S group. (F) The percentage of LAMP1 + /CD11b + CD45 high fluorescence intensity at 1 day and 3 days after HI. (G) Quantification of LAMP1 + /CD11b + CD45 low-med cells at 1 and 3 days after HI. (H) Quantification of LAMP1 + /CD11b + CD45 high cells at 1 and 3 days after HI. C, control group; HI-M, hypoxia-ischemia brain damage with mild injury; HI-S, hypoxia-ischemia brain damage with severe injury. * p < 0.05 HI-M vs. C, ** p < 0.01 HI-M vs. C, # p < 0.05 HI-S vs. C, △ p < 0.05 HI-S vs. HI-M, **** p < 0.0001 HI-M vs. C, # p < 0.05 HI-S vs. C, △ p < 0.05 HI-S vs. HI-M, n = 4–6 animals per group, data expressed as the means ± SEM.
    Anti Mouse Tlr2, supplied by InvivoGen, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse tlr2/product/InvivoGen
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti mouse tlr2 - by Bioz Stars, 2023-09
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    The expression of toll-like receptor 2 (TLR2) and lysosome-associated membrane protein 1 (LAMP1) on CD11b + CD45 low-med and CD11b + CD45 high cells in mild and severe brain injury after HI. (A) Percentage of TLR2 + /CD11b + CD45 low-med fluorescence intensity at 1 day and 3 days after HI in the C group, HI-M group, and HI-S group. (B) The percentage of TLR2 + /CD11b + CD45 high fluorescence intensity at 1 day and 3 days after HI. (C) Quantification of TLR2 + /CD11b + CD45 low-med cells at 1 and 3 days after HI. (D) Quantification of TLR2 + /CD11b + CD45 high cells at 1 and 3 days after HI. (E) The percentage of LAMP1 + /CD11b + CD45 low-med fluorescence intensity at 1 day and 3 days after HI in the C group, HI-M group, and HI-S group. (F) The percentage of LAMP1 + /CD11b + CD45 high fluorescence intensity at 1 day and 3 days after HI. (G) Quantification of LAMP1 + /CD11b + CD45 low-med cells at 1 and 3 days after HI. (H) Quantification of LAMP1 + /CD11b + CD45 high cells at 1 and 3 days after HI. C, control group; HI-M, hypoxia-ischemia brain damage with mild injury; HI-S, hypoxia-ischemia brain damage with severe injury. * p < 0.05 HI-M vs. C, ** p < 0.01 HI-M vs. C, # p < 0.05 HI-S vs. C, △ p < 0.05 HI-S vs. HI-M, **** p < 0.0001 HI-M vs. C, # p < 0.05 HI-S vs. C, △ p < 0.05 HI-S vs. HI-M, n = 4–6 animals per group, data expressed as the means ± SEM.

    Journal: Frontiers in Cellular Neuroscience

    Article Title: Distinct Residential and Infiltrated Macrophage Populations and Their Phagocytic Function in Mild and Severe Neonatal Hypoxic-Ischemic Brain Damage

    doi: 10.3389/fncel.2020.00244

    Figure Lengend Snippet: The expression of toll-like receptor 2 (TLR2) and lysosome-associated membrane protein 1 (LAMP1) on CD11b + CD45 low-med and CD11b + CD45 high cells in mild and severe brain injury after HI. (A) Percentage of TLR2 + /CD11b + CD45 low-med fluorescence intensity at 1 day and 3 days after HI in the C group, HI-M group, and HI-S group. (B) The percentage of TLR2 + /CD11b + CD45 high fluorescence intensity at 1 day and 3 days after HI. (C) Quantification of TLR2 + /CD11b + CD45 low-med cells at 1 and 3 days after HI. (D) Quantification of TLR2 + /CD11b + CD45 high cells at 1 and 3 days after HI. (E) The percentage of LAMP1 + /CD11b + CD45 low-med fluorescence intensity at 1 day and 3 days after HI in the C group, HI-M group, and HI-S group. (F) The percentage of LAMP1 + /CD11b + CD45 high fluorescence intensity at 1 day and 3 days after HI. (G) Quantification of LAMP1 + /CD11b + CD45 low-med cells at 1 and 3 days after HI. (H) Quantification of LAMP1 + /CD11b + CD45 high cells at 1 and 3 days after HI. C, control group; HI-M, hypoxia-ischemia brain damage with mild injury; HI-S, hypoxia-ischemia brain damage with severe injury. * p < 0.05 HI-M vs. C, ** p < 0.01 HI-M vs. C, # p < 0.05 HI-S vs. C, △ p < 0.05 HI-S vs. HI-M, **** p < 0.0001 HI-M vs. C, # p < 0.05 HI-S vs. C, △ p < 0.05 HI-S vs. HI-M, n = 4–6 animals per group, data expressed as the means ± SEM.

    Article Snippet: The following combinations of antibodies with a 1:100 dilution in staining buffer were used: (1) APC anti-mouse CD45 (Biolegend)/FITC anti-mouse CD11b (Biolegend)/PE anti-mouse CD36 (Biolegend)/PerCP anti-mouse LAMP1 (Nouvs); and (2) APC anti-mouse CD45 (Biolegend)/FITC anti-mouse CD11b (Biolegend)/PE anti-mouse TLR2 (Biolegend)/PerCP anti-mouse TGF-β (Biolegend).

    Techniques: Expressing, Fluorescence, Hi-C